Insider Transactions in Q2 2021 at Cen Biotech Inc (CENBF)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+26.48%
|
-
|
|
Jun 16
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
3,000
+0.11%
|
-
|
|
May 16
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
3,000
+0.17%
|
-
|
|
Apr 16
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
3,000
+0.17%
|
-
|
|
Apr 10
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
30,000
+1.66%
|
$30,000
$1.6 P/Share
|
|
Apr 02
2021
|
Donald Strilchuck Director |
BUY
Grant, award, or other acquisition
|
Direct |
341,250
+20.04%
|
-
|
|
Apr 02
2021
|
De Lavenu Harold Andre Aubrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,041,250
+39.07%
|
-
|
|
Apr 02
2021
|
Alex Tarrabain Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+14.47%
|
-
|
|
Apr 02
2021
|
Ameen Ferris Vice President* |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+49.51%
|
-
|
|
Apr 02
2021
|
Bahige B. Chaaban Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,106,122
+22.02%
|
-
|
|
Apr 02
2021
|
Brian Payne Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
1,435,000
+39.38%
|
-
|
|
Apr 02
2021
|
Richard Boswell Senior Executive VP |
BUY
Grant, award, or other acquisition
|
Direct |
2,185,679
+26.7%
|
-
|
|
Apr 02
2021
|
Usamakh Saadikh Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+49.51%
|
-
|